News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Dr. Kenneth Cheng to Speak At South Carolina Society of Nuclear Medicine Conference (Business Wire)...~~~ Dr. Cheng will discuss his clinical experience with Cotara(TM), Peregrine`s Tumor Necrosis Therapy (TNT) drug.......Dr. Cheng participated as a researcher in the Phase I and II brain cancer trials for Cotara that were conducted at the Medical University of South Carolina.......Cotara is a radiolabeled monoclonal antibody that targets the necrotic core of tumors....- Mar 02 7:51 AM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557